EDGAR Filing Documents for 0001062993-15-005902

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001062993-15-005902

Filing Date

2015-11-12

Accepted

2015-11-10 21:29:48

Documents

Period of Report

2015-09-30

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	form6k.htm	6-K	4849
2	EXHIBIT 99.1	exhibit99-1.htm	EX-99.1	330909
3	EXHIBIT 99.2	exhibit99-2.htm	EX-99.2	249711
4	EXHIBIT 99.3	exhibit99-3.htm	EX-99.3	7315
5	EXHIBIT 99.4	exhibit99-4.htm	EX-99.4	7303
6	GRAPHIC	trillogo.jpg	GRAPHIC	6558
7	GRAPHIC	exhibit99-2x6x1.jpg	GRAPHIC	33412
	Complete submission text file	0001062993-15-005902.txt		656400

Mailing Address 96 SKYWAY AVENUE TORONTO A6 M9W 4Y9

Business Address 96 SKYWAY AVENUE TORONTO A6 M9W 4Y9 (416) 595-0627

Trillium Therapeutics Inc. (Filer) CIK: 0001616212 (see all company filings)